XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 105 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q2 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $80,210 | -32.4% | 43,124 | -4.8% | 0.00% | – |
Q2 2023 | $118,659 | +386.4% | 45,290 | +202.6% | 0.00% | – |
Q1 2023 | $24,393 | +14.7% | 14,965 | -6.4% | 0.00% | – |
Q4 2022 | $21,272 | -84.1% | 15,994 | -81.4% | 0.00% | – |
Q3 2022 | $134,000 | -50.6% | 86,048 | -51.1% | 0.00% | – |
Q2 2022 | $271,000 | – | 176,127 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CAXTON CORP | 5,641,920 | $14,781,830 | 42.66% |
Stonepine Capital Management, LLC | 5,500,228 | $14,410,597 | 5.20% |
MPM BioImpact LLC | 3,974,999 | $10,414,497 | 2.10% |
Soleus Capital Management, L.P. | 2,054,105 | $5,381,755 | 0.60% |
EAM Investors, LLC | 757,962 | $1,985,860 | 0.37% |
DELTEC ASSET MANAGEMENT LLC | 406,190 | $1,064,218 | 0.23% |
Alpine Global Management, LLC | 225,000 | $589,500 | 0.18% |
Redmile Group, LLC | 1,046,587 | $2,742,058 | 0.10% |
IHT Wealth Management, LLC | 281,442 | $737,379 | 0.04% |
OCCUDO QUANTITATIVE STRATEGIES LP | 127,091 | $332,978 | 0.04% |